http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2482852-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa6178d16675e11ae09ee4bd579cb0b0 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
filingDate | 2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_668d707d73fa02f52afa6aaff1bf9720 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc60883ba2a196f76309fa798eeadc2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea689387dc70207c00efad496feba06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c07c412898ab4f67e3acaa1857664c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10c84fff829b86d8f7eb473811b20afb |
publicationDate | 2013-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2482852-C2 |
titleOfInvention | Pharmaceutical composition for treating dermatoses treated by glucocorticosteroids, and method for preparing it |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to medicine, and concerns a pharmaceutical composition for treating skin diseases. The composition contains a combination of methylprednisolone aceponate and glycoceramides and a glycoceramide complex containing cholesterol in the amount of 1-3%, and phospholipids in the amount of 25-34%, and excipients. A method for preparing the composition consists in the fact that methylprednisolone aceponate is introduced into an emulsion base containing the glycoceramide complex in the form of a solution to form a coagulation structure. n EFFECT: new pharmaceutical composition is characterised by a wide spectrum of pharmacological properties, stability, uniform distribution of the active ingredients. n 9 cl, 2 tbl |
priorityDate | 2011-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.